All stock lists
Bausch & Lomb Corp (NYSE:BLCO)
Canada · Delayed Price · Currency is USD
Healthcare · Medical Instruments & Supplies
17.65+0.18 (+1.03%)
Insider Score
––Not scored
BLCO Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
BLCO Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 1.39 B | 1.24 B | 1.41 B | 1.28 B | 1.28 B |
| Revenue Growth (YoY) | 9.08 % | — | — | — | — |
| Cost of Revenue | 527.00 M | 483.00 M | 533.00 M | 510.00 M | 525.00 M |
| Gross Profit | 867.00 M | 761.00 M | 872.00 M | 771.00 M | 753.00 M |
| SG&A Expense | 588.00 M | 544.00 M | 564.00 M | 528.00 M | 579.00 M |
| R&D Expense | 114.00 M | 101.00 M | 94.00 M | 95.00 M | 96.00 M |
| Operating Expenses | 759.00 M | 702.00 M | 714.00 M | 691.00 M | 742.00 M |
| Operating Income | 108.00 M | 59.00 M | 158.00 M | 80.00 M | 11.00 M |
| Pretax Income | -11.00 M | -64.00 M | 13.00 M | -3.00 M | -147.00 M |
| Tax Provision | -1.00 M | 6.00 M | 71.00 M | 22.00 M | -89.00 M |
| Net Income | -14.00 M | -71.00 M | -58.00 M | -28.00 M | -62.00 M |
| EPS (Basic) | -0.04 | -0.20 | -0.16 | -0.08 | -0.18 |
| EPS (Diluted) | -0.04 | -0.20 | -0.16 | -0.08 | -0.18 |
| Shares Outstanding | 357.10 M | 355.20 M | 354.40 M | 354.20 M | 353.70 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.